Left heart growth and biventricular repair after hybrid palliation

Vladimir Sojak1, Regina Bokenkamp2, Irene Kuipers3

  • 1Department of Thoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.

Insights

Hybrid palliation can promote left heart growth in infants with left ventricle hypoplasia, enabling more patients to achieve biventricular circulation. Further interventions may be necessary, and some may develop restrictive physiology.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Left ventricle hypoplasia presents complex challenges in infant cardiac surgery.
  • Initial hybrid palliation is a strategy to promote left heart growth before definitive repair.

Purpose of the Study:

  • To evaluate the outcomes of biventricular repair following initial hybrid palliation in infants with left ventricle hypoplasia.
  • To assess the effectiveness of hybrid palliation in facilitating left heart development.

Main Methods:

  • A cohort of 27 infants with left ventricle hypoplasia underwent biventricular repair after hybrid palliation (median age 11 days).
  • Indications for hybrid palliation included promoting left ventricle outflow tract/aortic valve growth (14 patients) or left ventricle growth (13 patients).
  • Interstage management included reinterventions and reoperations; subsequent biventricular repair procedures varied.

Main Results:

  • 85.2% of patients (23/27) survived at a median follow-up of 3.3 years.
  • Significant growth in left ventricle parameters was observed during the interstage period (median 62 days).
  • There were 22 reinterventions and 15 reoperations after biventricular repair.

Conclusions:

  • Hybrid palliation can stimulate left heart growth in select infants with left ventricle hypoplasia.
  • Biventricular circulation may be achievable in more patients than initially anticipated.
  • Ongoing monitoring and potential interventions are crucial due to the risk of restrictive physiology in some patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
147